Form 4: Privia Health Director Pamela Kimmet Receives Equity Grant Under Incentive Plan

Privia Health Group, Inc. Director Pamela O. Kimmet was granted 8,396 restricted stock units (RSUs) on May 21, 2025, as part of the company's 2021 Omnibus Incentive Plan.

Summary

• On May 21, 2025, Pamela O. Kimmet, a Director of Privia Health Group, Inc. (PRVA), acquired 8,396 shares of common stock in the form of restricted stock units (RSUs).
• The RSUs were granted at a price of $0 per unit, indicating they are part of an equity compensation plan.
• These RSUs were issued under the Issuer's 2021 Omnibus Incentive Plan.
• Following this transaction, Ms. Kimmet directly beneficially owns a total of 25,709 shares of common stock.
• The restricted stock units are set to vest on the earlier of (i) the day immediately preceding the Company's 2026 annual meeting of stockholders and (ii) the first anniversary of the grant date (May 21, 2025).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It's a routine compensation event that aligns director interests with shareholders, but does not indicate significant operational or financial news.

Positives

• The grant of restricted stock units aligns the interests of Director Pamela O. Kimmet with those of the shareholders, incentivizing long-term company performance.
• Equity compensation is a standard practice for retaining and motivating key personnel and board members.

Risks

• The value of the granted restricted stock units is subject to the future performance and market price of Privia Health Group, Inc.'s common stock.
• The RSUs are subject to a vesting schedule, meaning the director must remain with the company until the vesting conditions are met to fully realize the value.

Future Outlook

The grant of restricted stock units indicates a future alignment of the director's financial interests with the company's performance, with vesting scheduled for 2026.

Industry Context

The granting of restricted stock units to directors is a common practice across various industries, including healthcare services, as a form of non-cash compensation designed to align leadership incentives with shareholder value creation.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) as a component of director compensation is a widely adopted practice among publicly traded companies, including those in the healthcare sector, such as Teladoc Health (TDOC) or Amwell (AMWL), which also utilize equity grants to incentivize their board members.
• The vesting schedule, tied to either an annual meeting or a one-year anniversary, is typical for such grants, ensuring continued commitment from the director.

Stakeholder Impact

• Shareholders: The grant aligns the director's financial interests with the long-term performance of the company, potentially benefiting shareholders through improved governance and strategic decisions.
• Employees: While not directly impacting general employees, the use of incentive plans can signal a commitment to performance-based compensation across the organization.

Next Steps

• The restricted stock units will vest on the earlier of the day immediately preceding the Company's 2026 annual meeting of stockholders or May 21, 2026.

Key Dates

Recommendation

Keywords

Privia Health Group, PRVA, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU, Equity Compensation, Director Compensation, Beneficial Ownership, Incentive Plan